A number of countries have used the results of recent surveys of medicine prices and availability to inform and guide policy action to improve access to medicines. Examples include: China: The Chinese Government intends to limit the price of branded generics to not much higher than unbranded generics, simplify the public sector medicine supply system, establish a national pooled tendering procurement system and abolish mark-ups in the public sector. India: The Government has recently established retail outlets that only sell unbranded quality generics at no more than 50% of the prevailing maximum retail price. Lebanon: Following the 2004 survey, the Lebanese Government undertook.
